Breakthrough partnership with Universal Robots transforms "artisanal" manufacturing, making personalized, life-saving cancer treatments affordable and widely available. "This is a quantum leap in ...

A leading-edge cellular therapy for treating melanoma cancer known as TIL (tumor infiltrating lymphocytes) requires removal of part of the tumor, isolating the tumor’s immune cells, multiplying them, ...

Breakthrough partnership with Universal Robots transforms "artisanal" manufacturing, making personalized, life-saving cancer treatments affordable and widely available. Leveraging collaborative robots ...

Immunostaining (in green) for the Ca 2+ activated chloride channel TMEM16B on patient derived glioma stem cells. The blue color identifies nuclei. Chloride ion flows that enter the cells play an ...

Cancer cells have one relentless goal: to grow and divide. While most stick together within the original tumor, some rogue cells break away to traverse to distant organs. There, they can lie ...

Scientists have identified key changes to both chromosome structure and gene expression that affect stem cell function during aging. Using fruit flies, they found that these changes led to stem cell ...

Scientists from the RIKEN Center for Biosystems Dynamics Research (BDR) have identified key changes to both chromosome structure and gene expression that affect stem cell function during aging. Using ...

Automating Portal’s cell engineering platform using Multiply Labs’ robotic systems aims to reduce costs and accelerate timelines, in support of cell therapy scalability and accessibility CAMBRIDGE, ...

CPC Biotech, part of PSG and Dover (NYSE: DOV) and a leading manufacturer of connectors, pumps, and flow sensors used in biopharmaceutical processing, has collaborated with Multiply Labs to rapidly ...

Cancer cells have one relentless goal: to grow and divide. While most stick together within the original tumor, some rogue cells break away to traverse to distant organs. There, they can lie ...

Portal Biotechnologies and Multiply Labs announced a collaboration with the goal of leveraging automation to accelerate product timelines and reduce costs, helping innovative cell therapies reach more ...